How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?
Publication
, Journal Article
Knechtle, SJ
Published in: Nat Clin Pract Nephrol
December 2005
Duke Scholars
Published In
Nat Clin Pract Nephrol
DOI
ISSN
1745-8323
Publication Date
December 2005
Volume
1
Issue
2
Start / End Page
74 / 75
Location
England
Related Subject Headings
- Urology & Nephrology
- Time Factors
- Kidney Transplantation
- Immunosuppressive Agents
- Humans
- Graft Survival
- Cadaver
- Antibodies, Neoplasm
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal
Citation
APA
Chicago
ICMJE
MLA
NLM
Knechtle, S. J. (2005). How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation? Nat Clin Pract Nephrol, 1(2), 74–75. https://doi.org/10.1038/ncpneph0052
Knechtle, Stuart J. “How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?” Nat Clin Pract Nephrol 1, no. 2 (December 2005): 74–75. https://doi.org/10.1038/ncpneph0052.
Knechtle SJ. How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation? Nat Clin Pract Nephrol. 2005 Dec;1(2):74–5.
Knechtle, Stuart J. “How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?” Nat Clin Pract Nephrol, vol. 1, no. 2, Dec. 2005, pp. 74–75. Pubmed, doi:10.1038/ncpneph0052.
Knechtle SJ. How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation? Nat Clin Pract Nephrol. 2005 Dec;1(2):74–75.
Published In
Nat Clin Pract Nephrol
DOI
ISSN
1745-8323
Publication Date
December 2005
Volume
1
Issue
2
Start / End Page
74 / 75
Location
England
Related Subject Headings
- Urology & Nephrology
- Time Factors
- Kidney Transplantation
- Immunosuppressive Agents
- Humans
- Graft Survival
- Cadaver
- Antibodies, Neoplasm
- Antibodies, Monoclonal, Humanized
- Antibodies, Monoclonal